Cleveland Clinic researchers have identified a gut microbe-generated byproduct -- phenylacetylglutamine (PAG) -- that is linked to development of cardiovascular disease, including heart attack, stroke and death. The study was published in Cell today.
Researchers discover a new diet-associated gut-microbe metabolite linked to cardiovascular disease
- 5. 3 2020 (06:00)